Literature DB >> 1280190

Cardiac arrhythmias during postural drainage and chest percussion of critically ill patients.

W E Hammon1, A F Connors, D R McCaffree.   

Abstract

In this study we determine the prevalence and type of arrhythmias that occur during postural drainage and chest percussion (PDP) of critically ill patients, and identify those patients who are most at risk of developing them. We monitored the vital signs and ECGs of 72 ICU patients during their initial PDP treatment. Eight patients (11.1 percent) had development of major arrhythmias, 18 (25 percent) had minor arrhythmias, and 46 (63.9 percent) had none. Increased age (p < 0.0001) and the presence of acute cardiac disorders (p < 0.001) were associated with increased risk of arrhythmias. Individuals experiencing major arrhythmias had a significantly decreased BP and respiratory rate with an increased heart rate during PDP. We conclude that arrhythmias are common during PDP of critically ill patients and recommend that ICU patients be carefully monitored during PDP. When considering PDP for older patients and patients with acute cardiac disease, physicians should carefully weigh the risk of arrhythmias against the benefits of this treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1280190     DOI: 10.1378/chest.102.6.1836

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  3 in total

1.  Acute Total Lung Collapse in a Woman with Acute Stroke and Atrial Fibrillation.

Authors:  Karanam Gowrinath; Gangapatnam Vamsidhar Reddy
Journal:  J Clin Diagn Res       Date:  2017-02-01

2.  Chest physiotherapy prolongs duration of ventilation in the critically ill ventilated for more than 48 hours.

Authors:  Maie Templeton; Mark G A Palazzo
Journal:  Intensive Care Med       Date:  2007-07-03       Impact factor: 17.440

Review 3.  Clinical review: airway hygiene in the intensive care unit.

Authors:  Sanja Jelic; Jennifer A Cunningham; Phillip Factor
Journal:  Crit Care       Date:  2008-03-31       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.